Cargando…
Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
BACKGROUND: Recent Genome Wide Association Studies (GWAS) have identified novel rare coding variants in immune genes associated with late onset Alzheimer’s disease (LOAD). Amongst these, a polymorphism in phospholipase C-gamma 2 (PLCG2) P522R has been reported to be protective against LOAD. PLC enzy...
Autores principales: | Magno, Lorenza, Lessard, Christian B., Martins, Marta, Lang, Verena, Cruz, Pedro, Asi, Yasmine, Katan, Matilda, Bilsland, Jamie, Lashley, Tammaryn, Chakrabarty, Paramita, Golde, Todd E., Whiting, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359863/ https://www.ncbi.nlm.nih.gov/pubmed/30711010 http://dx.doi.org/10.1186/s13195-019-0469-0 |
Ejemplares similares
-
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations
por: Martín-Nalda, Andrea, et al.
Publicado: (2020) -
Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa
por: Neves, João Farela, et al.
Publicado: (2018) -
Heterogeneous Nuclear Ribonucleoproteins: Implications in Neurological Diseases
por: Low, Yi-Hua, et al.
Publicado: (2020) -
Four diseases, PLAID, APLAID, FCAS3 and CVID and one gene (PHOSPHOLIPASE C, GAMMA‐2; PLCG2): Striking clinical phenotypic overlap and difference
por: Kutukculer, Necil, et al.
Publicado: (2021) -
Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma
por: Prenen, Hans, et al.
Publicado: (2015)